ALK Monoclonal antibody
ALK Monoclonal Antibody for IHC, ELISA
Host / Isotype
Mouse / IgG2a
Reactivity
human
Applications
IHC, ELISA and More (1)
Conjugate
Unconjugated
CloneNo.
7G9E3
验证数据展示
经过测试的应用
Positive IHC detected in | human lymphoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
Application | Dilution |
---|---|
Immunohistochemistry (IHC) | IHC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
WB | See 3 publications below |
产品信息
60321-1-Ig targets ALK in WB, IHC, ELISA applications and shows reactivity with human samples.
Tested Applications | IHC, ELISA Application Description |
Cited Applications | WB |
Tested Reactivity | human |
Cited Reactivity | human |
Immunogen | ALK fusion protein Ag21493 种属同源性预测 |
Host / Isotype | Mouse / IgG2a |
Class | Monoclonal |
Type | Antibody |
Full Name | anaplastic lymphoma receptor tyrosine kinase |
Synonyms | ALK, ALK tyrosine kinase receptor, Anaplastic lymphoma kinase, CD246, TFG/ALK |
Calculated Molecular Weight | 1620 aa, 176 kDa |
GenBank Accession Number | NM_004304 |
Gene Symbol | ALK |
Gene ID (NCBI) | 238 |
RRID | AB_2881432 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
UNIPROT ID | Q9UM73 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
实验方案
Product Specific Protocols | |
---|---|
IHC protocol for ALK antibody 60321-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Eur J Med Chem Discovery of 2,4-pyrimidinediamine derivatives as potent dual inhibitors of ALK and HDAC. | ||
iScience DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer |